HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xavier Bertagna Selected Research

Acth-Independent Macronodular Adrenal Hyperplasia

11/2013ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome.
7/2010Aberrant cortisol regulations in bilateral macronodular adrenal hyperplasia: a frequent finding in a prospective study of 32 patients with overt or subclinical Cushing's syndrome.
6/2008Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors.
3/2005In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism.
11/2002cAMP pathway alterations from the cell surface to the nucleus in adrenocortical tumors.
5/2002The ectopic expression of the gastric inhibitory polypeptide receptor is frequent in adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia, but rare in unilateral tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xavier Bertagna Research Topics

Disease

51Neoplasms (Cancer)
10/2019 - 01/2002
29Cushing Syndrome
01/2020 - 05/2002
14Adrenocortical Carcinoma
12/2015 - 08/2003
12Pituitary ACTH Hypersecretion
01/2020 - 01/2004
11Hyperplasia
01/2017 - 05/2002
10Adenoma (Adenomas)
01/2015 - 05/2002
8Adrenocortical Adenoma (Disease, Conn's)
09/2015 - 08/2003
8Adrenal Cortex Neoplasms (Adrenocortical Cancer)
01/2013 - 11/2002
6Acth-Independent Macronodular Adrenal Hyperplasia
11/2013 - 05/2002
6Carcinogenesis
11/2010 - 12/2002
5Carney Complex
11/2015 - 12/2002
5Carcinoma (Carcinomatosis)
01/2013 - 03/2005
5Neoplasm Metastasis (Metastasis)
12/2012 - 06/2004
4Adrenal Insufficiency (Adrenal Gland Hypofunction)
04/2016 - 11/2003
4Paraganglioma (Paragangliomas)
10/2013 - 10/2004
4Pheochromocytoma
10/2013 - 10/2004
3ACTH-Secreting Pituitary Adenoma
04/2012 - 01/2009
2Hypogonadism (Hypergonadotropic Hypogonadism)
01/2013 - 11/2003
2Carcinoid Tumor (Carcinoid)
12/2012 - 11/2002
2Pituitary Neoplasms (Pituitary Adenoma)
10/2012 - 05/2007
2Myxoma (Myxomas)
06/2009 - 05/2006
2Acromegaly
06/2008 - 07/2007
2Prolactinoma (Prolactinomas)
05/2007 - 07/2004
1Chromosomal Instability (Chromosome Stability)
01/2020
1Endocrine System Diseases (Endocrine Diseases)
06/2016
1Diarrhea
04/2016
1Asthenia
04/2016
1Hirsutism
04/2016
1Acne Vulgaris
04/2016
1Nausea
04/2016
1Endocrine Gland Neoplasms (Cancer, Endocrine)
01/2014
1Adrenal incidentaloma
12/2011
1Pancreatic Neoplasms (Pancreatic Cancer)
11/2011
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
01/2011
1Necrosis
01/2011
1Testicular Neoplasms (Testicular Cancer)
01/2011
1Ectopic ACTH Syndrome
10/2009

Drug/Important Bio-Agent (IBA)

21Hydrocortisone (Cortisol)FDA LinkGeneric
01/2020 - 05/2002
21Adrenocorticotropic Hormone (ACTH)FDA Link
01/2020 - 05/2002
11DNA (Deoxyribonucleic Acid)IBA
01/2020 - 10/2004
8Proteins (Proteins, Gene)FDA Link
11/2011 - 11/2002
6Mitotane (Lysodren)FDA Link
04/2013 - 07/2006
6SteroidsIBA
12/2011 - 01/2002
6Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
01/2011 - 12/2002
5GlucocorticoidsIBA
01/2013 - 05/2006
5Cyclic AMP (AMP, Cyclic)IBA
06/2008 - 01/2002
5Insulin-Like Growth Factor II (Somatomedin A)IBA
05/2005 - 01/2002
4AndrogensIBA
01/2013 - 07/2006
4CateninsIBA
02/2011 - 11/2010
4Biological ProductsIBA
11/2010 - 07/2006
3OsilodrostatIBA
01/2020 - 04/2014
3Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
01/2011 - 07/2006
3beta CateninIBA
11/2010 - 09/2005
3Hormones (Hormone)IBA
01/2008 - 11/2002
3Carrier Proteins (Binding Protein)IBA
07/2006 - 11/2002
3Messenger RNA (mRNA)IBA
05/2005 - 12/2002
2Biomarkers (Surrogate Marker)IBA
10/2019 - 12/2011
2ProgesteroneFDA LinkGeneric
12/2015 - 06/2008
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2015 - 06/2004
2Insulin-Like PeptidesIBA
01/2014 - 11/2006
2Adenosine (Adenocard)FDA LinkGeneric
10/2008 - 08/2003
2CatecholaminesIBA
01/2008 - 01/2002
2Succinate Dehydrogenase (Fumarate Reductase)IBA
10/2007 - 10/2004
2aryl hydrocarbon receptor-interacting proteinIBA
07/2007 - 05/2007
2ProlactinIBA
07/2007 - 05/2007
2Pro-Opiomelanocortin (Proopiomelanocortin)IBA
01/2007 - 11/2002
2ElementsIBA
07/2006 - 08/2003
2EnzymesIBA
03/2005 - 11/2003
2gastric inhibitory polypeptide receptorIBA
01/2003 - 05/2002
1Mixed Function Oxygenases (Monooxygenases)IBA
01/2020
1Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA
01/2020
1Testosterone (Sustanon)FDA Link
04/2016
1Estradiol (Delestrogen)FDA LinkGeneric
12/2015
1AdosterolIBA
11/2015
1LipidsIBA
09/2015
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2014
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2014
1Mifepristone (RU 486)FDA Link
04/2013
1Ketoconazole (Nizoral)FDA LinkGeneric
04/2013
1CabergolineFDA LinkGeneric
04/2013
1MetyraponeFDA Link
04/2013
1Pharmaceutical PreparationsIBA
04/2013
1pasireotideIBA
04/2013
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
04/2013
1Cytochrome P-450 CYP3AIBA
01/2013
1Dopamine Receptors (Dopamine Receptor)IBA
04/2012
1somatostatin receptor 5IBA
04/2012
1Steroidogenic Factor 1IBA
02/2012
1diphenyl (biphenyl)IBA
02/2010
1EthaneIBA
02/2010
1Dexamethasone (Maxidex)FDA LinkGeneric
10/2009
1CholesterolIBA
10/2009
1P-2 (P 2)IBA
03/2009

Therapy/Procedure

7Therapeutics
01/2014 - 09/2005
7Adrenalectomy
04/2013 - 01/2004
2Pituitary Irradiation
04/2011 - 01/2007
1Radiotherapy
04/2013
1Ligation
01/2013
1Lymph Node Excision (Lymph Node Dissection)
12/2012
1Hypophysectomy
12/2012